Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of Vera Therapeutics Inc (NASDAQ: VERA) was $48.62 for the day, down -3.99% from the previous closing price of $50.64. In other words, the price has decreased by -$3.99 from its previous closing price. On the day, 1.03 million shares were traded. VERA stock price reached its highest trading level at $50.84 during the session, while it also had its lowest trading level at $47.94.
Ratios:
Our analysis of VERA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 12.09 and its Current Ratio is at 12.09. In the meantime, Its Debt-to-Equity ratio is 0.19 whereas as Long-Term Debt/Eq ratio is at 0.19.
Upgrades & Downgrades
In the most recent recommendation for this company, BofA Securities on October 16, 2025, initiated with a Buy rating and assigned the stock a target price of $48.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 15 ’25 when Turner William D. sold 10,000 shares for $50.08 per share. The transaction valued at 500,767 led to the insider holds 22,500 shares of the business.
ENRIGHT PATRICK G bought 5,882 shares of VERA for $249,985 on Dec 11 ’25. The Director now owns 5,882 shares after completing the transaction at $42.50 per share. On Dec 15 ’25, another insider, WILLIAM TURNER, who serves as the Officer of the company, bought 10,000 shares for $49.80 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VERA now has a Market Capitalization of 3451382528 and an Enterprise Value of 2688009472.
Stock Price History:
The Beta on a monthly basis for VERA is 1.16, which has changed by 0.15049696 over the last 52 weeks, in comparison to a change of 0.14778805 over the same period for the S&P500. Over the past 52 weeks, VERA has reached a high of $56.05, while it has fallen to a 52-week low of $18.53. The 50-Day Moving Average of the stock is 30.23%, while the 200-Day Moving Average is calculated to be 78.90%.
Shares Statistics:
VERA traded an average of 1.52M shares per day over the past three months and 1135490 shares per day over the past ten days. A total of 63.89M shares are outstanding, with a floating share count of 53.33M. Insiders hold about 23.88% of the company’s shares, while institutions hold 83.82% stake in the company. Shares short for VERA as of 1765756800 were 9145275 with a Short Ratio of 6.03, compared to 1763078400 on 9962227. Therefore, it implies a Short% of Shares Outstanding of 9145275 and a Short% of Float of 14.62.
Earnings Estimates
. The current rating of Vera Therapeutics Inc (VERA) reflects the combined expertise of 8.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$1.23, with high estimates of -$0.98 and low estimates of -$1.67.
Analysts are recommending an EPS of between -$3.86 and -$4.96 for the fiscal current year, implying an average EPS of -$4.44. EPS for the following year is -$4.52, with 8.0 analysts recommending between -$3.18 and -$6.05.
